PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
73.80
-0.05 (-0.07%)
Jun 1, 2026, 4:00 PM EDT - Market closed
PTC Therapeutics Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, PTC Therapeutics stock has a consensus rating of "Buy" and an average price target of $91.57. The average 1-year stock price forecast is 24.08% higher than the current stock price, while the lowest is $65 (-11.92%) and the highest is $124 (+68.02%).
Price Target: $91.57 (+24.08%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PTC Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 6 | 5 | 5 | 6 |
| Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Hold | 5 | 4 | 4 | 5 | 5 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 15 | 15 | 14 | 14 | 15 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Upgrades $76 → $85 | Buy | Upgrades | $76 → $85 | +15.18% | May 27, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $80 → $89 | Buy | Maintains | $80 → $89 | +20.60% | May 11, 2026 |
| Barclays | Barclays | Buy Maintains $120 | Buy | Maintains | $120 | +62.60% | May 11, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $81 → $82 | Hold | Maintains | $81 → $82 | +11.11% | May 8, 2026 |
Financial Forecast
Revenue This Year
1.16B
from 1.73B
Decreased by -32.92%
Revenue Next Year
1.29B
from 1.16B
Increased by 11.25%
EPS This Year
0.65
from 7.78
Decreased by -91.70%
EPS Next Year
2.16
from 0.65
Increased by 235.14%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.2B | ||
| Avg | 1.2B | ||
| Low | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -28.6% | ||
| Avg | -32.9% | ||
| Low | -37.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.27 | ||
| Avg | 0.65 | ||
| Low | -1.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -57.9% | ||
| Avg | -91.7% | ||
| Low | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.